Reproductive/GU Flashcards
Drug class for Folic Acid
water soluble vitamin
Indications for Folic Acid
supplement to prevent neural tube defects
MoA for Folic Acid
required for formation of multiple co-enzymes in protein synthesis
Drug class for Pyridoxine + Doxylamine
anti-nauseants
Doxylamine=antihistamine
Pyridoxin=Vit B6
Indications for Pyridoxine + Doxylamine
N/V in pregnancy
MoA for Pyridoxine + Doxylamine
inhibits CRTZ; diminishes vestibular stimulation; depresses labyrinthine function; sedating
Drug class for Methyldopa
anti-hypertensive: central alpha adrenergic inhibitor
Indications for Methyldopa
HTN in PG
MoA for Methyldopa
central alpha-adrenergic inhibition decreasing sympathetic outflow to heart, kidneys, peripheral vasculature
Drug class for Labetalol
anti-hypertensive: non-selective alpha1 & beta receptor blocker
Indications for Labetalol
HTN in PG
MoA for Labetalol
blocks alpha, beta1, beta2 adrenergic receptors
Drug class for Magnesium sulfate
tocolytic agent
Indications for Magnesium sulfate
premature labor/eclampsia; seizure; torsade de pointes; severe Mg deficiency; unresponsive status asthmaticus (kids)
MoA for Magnesium sulfate
decreased AcH in motor nerve terminals; slows rate SA node impulse formation; relaxation of bronchial smooth muscle
Drug class for Loestrin Fe 1/20
COC: monophasic
Drug class for Lo Loestrin Fe
COC: biphasic
Indications for Loestrin Fe 1/20 & Lo Loestrin Fe
contraception
Drug class for Triphasil
COC: triphasic
Drug class for Natazia
COC: quadriphasic
Indications for Triphasil & Natazia
contraception, peri-menopause
MoA for Loestrin Fe 1/20, Lo Loestrin Fe, Triphasil, Natazia
suppression of FSH, LH w/ suppression of ovulation, & reduced implantation, thickening cervical mucus, decrease tubal mortality
Drug class for Ovrette
Progestin-only OC
Indications for Ovrette
contraception; especially in women where COC is contra-indicated
MoA for Ovrette
prevent mid-cycle FSH/LH surge, inhibit ovulation, inhibit implantation, thicken cervical mucus, slow tubal transport
Drug class for Lybrel
extended cycle OC
Indications for Lybrel & Quartette
contraception; women w/ menstrual related sxs (HA, menorrhagia, anemia, endometriosis-pain)
MoA for Lybrel & Quartette
prevent mid-cycle FSH/LH surge, inhibit implantation, thicken cervical mucus, slow tubal transport
Drug class for Quartette
quadriphasic ascending dose: extended cycle OC
Drug class for Conjugated Equine Estrogen CEE [Premarin]
Estrogen
Indications for CEE [Premarin]
moderate to severe vasomotor sxs; vaginal mucosal atrophy, hypogonadism
MoA for CEE [Premarin]
estrogen supplement
Drug class for MPA [Provera]
progesterone
Indications for MPA [Provera]
contraception; esp in women who have contra-indications for EE
MoA for MPA [Provera]
prevent mid-cycle FSH/LH surge, inhibit ovulation, inhibit implantation, thicken cervical mucus, slow tubal transport
Drug class for Mifepristone
abortifactant
Indications for Mifepristone
early pregnancy termination
MoA for Mifepristone
inhibits progesterone receptors, antagonizing endometrial & myometrial effects
Drug class for Ulipristal
post exposure contraception
Indications for Ulipristal
emergency contraception
MoA for Ulipristal
binds to progesterone receptor, inhibiting or delaying ovulation; alters endometrium possibly preventing implantation
Drug class for Flibanserin
mixed 5-HT1A agonist/5-HT2A agonist
Indications for Flibanserin
acquired generalized hypoactive sexual desire disorder in premenopausal females
MoA for Flibanserin
not known, although is known to be an agonist at 5-HT1A & antagonist at 5-HT2A receptors: moderate activity at other CNS receptors
Drug class for Ospemifene
selective estrogen receptor modulator
Indications for Ospemifene
moderate to severe dyspareunia due to vulvar/vaginal atrophy in postmenopausal females
MoA for Ospemifene
selective activation/inhibition of estrogen pathways in different tissues; agonistic effects on endometrium
Drug class for Metronidazole
antibiotic
Indications for Metronidazole
trichomoniasis, bacterial vaginosis
MoA for Metronidazole
inhibits protein synthesis in susceptible organisms when chemical structure is reduced
Drug class for Ceftriaxone
antibiotic
Indications for Ceftriaxone
gonorrhea
MoA for Ceftriaxone
in actively growing bacterial cells, interferes w/ transpeptidation of bacterial cell walls by binding to penicillin binding protein
Drug class for Azithromycin
antibiotic
Indications for Azithromycin
chlamydia, PID, acute bacterial exacerbations
MoA for Azithromycin
reversibly binds to 50S subunit of bacterial ribosome & inhibit protein synthesis
Drug class for Benthazine Penicillin G
antibiotic
Indications for Benthazine Penicillin G
syphilis
Drug class for Nitrofurantoin
antibiotic
Indications for Nitrofurantoin
px/tx of UTIs
MoA for Nitrofurantoin
inhibits several bacterial enzyme systems (acetyl CoA) interfering w/ metabolism & possibly cell wall synthesis
Drug class for Doxycycline
antibiotic
Indications for Doxycycline
syphilis
MoA for Doxycycline
interferers w/ bacterial 30S ribosome protein production
Drug class for Tenofovir/Emtricitabine
anti-retroviral
Indications for Tenofovir/Emtricitabine
HIV1, HIV prophylaxis
MoA for Tenofovir/Emtricitabine
each interferes w/ DNA polymerase function resulting in viral inhibition
Drug class for Valacyclovir
antiviral
Indications for Valacyclovir
mucocutaneous HSV 1 & 2, VZV infections
MoA for Valacyclovir
inhibits viral DNA synthesis & viral replication
Drug class for Clotrimazole cream
anti-fungal
Indications for Clotrimazole cream
candidiasis (vulvovaginal or breast)
MoA for Clotrimazole cream
alters fungal cell wall permeability & mess up fungi in other ways
Drug class for Ibuprofen
NSAIDs
Indications for Ibuprofen
pain secondary to inflammation in selected patients
MoA for Ibuprofen
inhibits COX1 & COX2 enzymes reducing PG, prostacyclin, thrombaxone
Drug class for Finasteride
5alpha-reductase inhibitor
Indications for Finasteride
benign prostatic disease (generally second-line for moderate-severe BPH)
MoA for Finasteride
decreases prostatic tissue growth secondary to inhibiting conversion of testosterone to dihydrotestosterone
Drug class for Tamulosin
alpha1 adrenergic antagonist
Indications for Tamulosin
benign prostatic disease (moderate-severe symptoms)
MoA for Tamulosin
relax bladder neck, prostatic urethra, prostatic smooth muscle
Drug class for Leuprolide
anti-androgen
Indications for Leuprolide
palliative treatment for prostate cancer; endometriosis
MoA for Leuprolide
GnRH agonist; agonist of LHRH
Drug class for Flutamide
anti-androgen
Indications for Flutamide
metastatic prostate cancer w/ LHRH agonist
MoA for Flutamide
non-steroidal anti-androgen that inhibits androgen binding in target tissues
Drug class for Testosterone
sex hormone androgen
Indications for Testosterone
hypogonadism
MoA for Testosterone
replacement
Drug class for Imipramine
tricyclic antidepressant
Indications for Imipramine
depression; off label for anti-cholinergic impact on UI
MoA for Imipramine
increase synaptic [serotonin, NE]; down regulation of beta-adrenergic receptors; anti-cholinergic effect
Drug class for Tolterodine & Oxybutinin
M3 antimuscarininc
Indications for Tolterodine & Oxybutinin
overactive bladder, urge incontinence
MoA for Tolterodine & Oxybutinin
selective antagonists of bladder muscarinic receptors decrease detrusor muscle pressure, increase residual urine volume
Drug class for Sildenafil & Tadalafil
PDE5 inhibitor
Indications for Sildenafil & Tadalafil
erectile dysfunction; pulm artery hypertension
MoA for Sildenafil & Tadalafil
inhibits PDE5 to increase [NO] leading to corpus cavernous relaxation & inflow of blood to cause erection
Drug class for Mirabegron
beta3 agonist
Indications for Mirabegron
overactive bladder w/ sxs of urinary frequency, urgency, or urge incontinence
MoA for Mirabegron
activates beta-3 adrenergic receptors in bladder relaxing detrusor muscle during urine storage phase